Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T00442 | Target Info | |||
Target Name | HUMAN catechol-O-methyl-transferase (COMT) | ||||
Synonyms | S-COMT; MB-COMT; Catechol-O-methyltransferase; COMT | ||||
Gene Name | COMT | ||||
Biochemical Class | Methyltransferase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Ademetionine | Ligand Info | |||
Canonical SMILES | C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O | ||||
InChI | 1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1 | ||||
InChIKey | MEFKEPWMEQBLKI-AIRLBKTGSA-N | ||||
PubChem Compound ID | 34755 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6I3C Crystal structure of Human soluble catechol O-methyltransferase in complex with 3,5-dinitrocatechol and S-adensoyl-L-methionine | ||||||
Method | X-ray diffraction | Resolution | 1.34 Å | Mutation | No | [1] |
PDB Sequence |
GDTKEQRILN
11 HVLQHAEPGN21 AQSVLEAIDT31 YCEQKEWAMN41 VGDKKGKIVD51 AVIQEHQPSV 61 LLELGAYCGY71 SAVRMARLLS81 PGARLITIEI91 NPDCAAITQR101 MVDFAGVKDK 111 VTLVVGASQD121 IIPQLKKKYD131 VDTLDMVFLD141 HWKDRYLPDT151 LLLEECGLLR 161 KGTVLLADNV171 ICPGAPDFLA181 HVRGSSCFEC191 THYQSFLEYR201 EVVDGLEKAI 211 YKGP
|
|||||
|
MET40
3.342
ASN41
3.742
VAL42
2.866
GLU64
3.983
GLY66
2.942
ALA67
3.599
TYR68
3.357
GLY70
4.630
TYR71
3.386
SER72
2.795
ILE89
3.711
GLU90
2.765
ILE91
3.271
|
|||||
PDB ID: 5LSA human catechol O-methyltransferase in complex with SAM and DNC at 1.50A | ||||||
Method | X-ray diffraction | Resolution | 1.50 Å | Mutation | No | [2] |
PDB Sequence |
DTKEQRILNH
62 VLQHAEPGNA72 QSVLEAIDTY82 CEQKEWAMNV92 GDKKGKIVDA102 VIQEHQPSVL 112 LELGAYCGYS122 AVRMARLLSP132 GARLITIEIN142 PDCAAITQRM152 VDFAGVKDKV 162 TLVVGASQDI172 IPQLKKKYDV182 DTLDMVFLDH192 WKDRYLPDTL202 LLEECGLLRK 212 GTVLLADNVI222 CPGAPDFLAH232 VRGSSCFECT242 HYQSFLEYRE252 VVDGLEKAIY 262 KGPG
|
|||||
|
MET90
3.426
ASN91
3.685
VAL92
2.814
GLU114
3.967
LEU115
4.998
GLY116
2.924
ALA117
3.556
TYR118
3.316
GLY120
4.536
TYR121
3.239
SER122
2.834
ILE139
3.665
GLU140
2.712
|
|||||
PDB ID: 4XUC Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of catechol-O-methyltransferase (COMT): Structure with Cmpd18 (1-(biphenyl-3-yl)-3-hydroxypyridin-4(1H)-one) | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | Yes | [3] |
PDB Sequence |
NLLAGDTKEQ
57 RILNHVLQHA67 EPGNAQSVLE77 AIDTYCEQKE87 WAMNVGDKKG97 KIVDAVIQEH 107 QPSVLLELGA117 YCGYSAVRMA127 RLLSPGARLI137 TIEINPDCAA147 ITQRMVDFAG 157 VKDKVTLVVG167 ASQDIIPQLK177 KKYDVDTLDM187 VFLDHWKDRY197 LPDTLLLEEC 207 GLLRKGTVLL217 ADNVICPGAP227 DFLAHVRGSS237 CFECTHYQSF247 LEYREVVDGL 257 EKAIYKGP
|
|||||
|
MET90
3.327
ASN91
3.636
VAL92
2.775
GLU114
3.804
GLY116
2.784
ALA117
3.532
TYR118
3.392
GLY120
4.589
TYR121
3.299
SER122
2.785
ILE139
3.823
GLU140
2.645
ILE141
3.245
|
|||||
PDB ID: 4XUD Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of catechol-O-methyltransferase (COMT): Structure with Cmpd32 ([1-(biphenyl-3-yl)-5-hydroxy-4-oxo-1,4-dihydropyridin-3-yl]boronic acid) | ||||||
Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | Yes | [3] |
PDB Sequence |
NLLAGDTKEQ
57 RILNHVLQHA67 EPGNAQSVLE77 AIDTYCEQKE87 WAMNVGDKKG97 KIVDAVIQEH 107 QPSVLLELGA117 YCGYSAVRMA127 RLLSPGARLI137 TIEINPDCAA147 ITQRMVDFAG 157 VKDKVTLVVG167 ASQDIIPQLK177 KKYDVDTLDM187 VFLDHWKDRY197 LPDTLLLEEC 207 GLLRKGTVLL217 ADNVICPGAP227 DFLAHVRGSS237 CFECTHYQSF247 LEYREVVDGL 257 EKAIYKGP
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SAM or .SAM2 or .SAM3 or :3SAM;style chemicals stick;color identity;select .A:90 or .A:91 or .A:92 or .A:114 or .A:116 or .A:117 or .A:118 or .A:120 or .A:121 or .A:122 or .A:139 or .A:140 or .A:141 or .A:142 or .A:145 or .A:167 or .A:168 or .A:169 or .A:170 or .A:189 or .A:191 or .A:192 or .A:193 or .A:194 or .A:196 or .A:200; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
MET90
3.270
ASN91
3.624
VAL92
2.811
GLU114
3.819
GLY116
2.951
ALA117
3.362
TYR118
3.557
GLY120
4.560
TYR121
3.291
SER122
2.876
ILE139
3.613
GLU140
2.704
ILE141
3.181
|
|||||
PDB ID: 3A7E Crystal structure of human COMT complexed with SAM and 3,5-dinitrocatechol | ||||||
Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | No | [4] |
PDB Sequence |
DTKEQRILNH
12 VLQHAEPGNA22 QSVLEAIDTY32 CEQKEWAMNV42 GDKKGKIVDA52 VIQEHQPSVL 62 LELGAYCGYS72 AVRMARLLSP82 GARLITIEIN92 PDCAAITQRM102 VDFAGVKDKV 112 TLVVGASQDI122 IPQLKKKYDV132 DTLDMVFLDH142 WKDRYLPDTL152 LLEECGLLRK 162 GTVLLADNVI172 CPGAPDFLAH182 VRGSSCFECT192 HYQSFLEYRE202 VVDGLEKAIY 212 KG
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SAM or .SAM2 or .SAM3 or :3SAM;style chemicals stick;color identity;select .A:40 or .A:41 or .A:42 or .A:64 or .A:65 or .A:66 or .A:67 or .A:68 or .A:70 or .A:71 or .A:72 or .A:89 or .A:90 or .A:91 or .A:92 or .A:95 or .A:117 or .A:118 or .A:119 or .A:120 or .A:139 or .A:141 or .A:142 or .A:143 or .A:144 or .A:146 or .A:150 or .A:170; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
MET40
3.260
ASN41
3.742
VAL42
2.977
GLU64
3.558
LEU65
4.887
GLY66
2.823
ALA67
3.317
TYR68
3.578
GLY70
4.824
TYR71
3.479
SER72
2.886
ILE89
3.249
GLU90
2.492
ILE91
3.247
|
|||||
PDB ID: 4XUE Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of catechol-O-methyltransferase (COMT): Structure with Cmpd27b | ||||||
Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | No | [3] |
PDB Sequence |
AGDTKEQRIL
60 NHVLQHAEPG70 NAQSVLEAID80 TYCEQKEWAM90 NVGDKKGKIV100 DAVIQEHQPS 110 VLLELGAYCG120 YSAVRMARLL130 SPGARLITIE140 INPDCAAITQ150 RMVDFAGVKD 160 KVTLVVGASQ170 DIIPQLKKKY180 DVDTLDMVFL190 DHWKDRYLPD200 TLLLEECGLL 210 RKGTVLLADN220 VICPGAPDFL230 AHVRGSSCFE240 CTHYQSFLEY250 REVVDGLEKA 260 IYKGP
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SAM or .SAM2 or .SAM3 or :3SAM;style chemicals stick;color identity;select .B:90 or .B:91 or .B:92 or .B:114 or .B:115 or .B:116 or .B:117 or .B:118 or .B:120 or .B:121 or .B:122 or .B:139 or .B:140 or .B:141 or .B:142 or .B:145 or .B:167 or .B:168 or .B:169 or .B:170 or .B:189 or .B:191 or .B:192 or .B:193 or .B:194 or .B:196 or .B:200; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
MET90
3.211
ASN91
3.653
VAL92
2.785
GLU114
4.127
LEU115
4.961
GLY116
2.851
ALA117
3.665
TYR118
3.344
GLY120
4.562
TYR121
3.217
SER122
2.900
ILE139
3.586
GLU140
2.747
ILE141
3.263
|
|||||
PDB ID: 3BWY Crystal Structure of Human 108M Catechol O-methyltransferase bound with S-adenosylmethionine and inhibitor dinitrocatechol | ||||||
Method | X-ray diffraction | Resolution | 1.30 Å | Mutation | No | [5] |
PDB Sequence |
GDTKEQRILN
11 HVLQHAEPGN21 AQSVLEAIDT31 YCEQKEWAMN41 VGDKKGKIVD51 AVIQEHQPSV 61 LLELGAYCGY71 SAVRMARLLS81 PGARLITIEI91 NPDCAAITQR101 MVDFAGMKDK 111 VTLVVGASQD121 IIPQLKKKYD131 VDTLDMVFLD141 HWKDRYLPDT151 LLLEECGLLR 161 KGTVLLADNV171 ICPGAPDFLA181 HVRGSSCFEC191 THYQSFLEYR201 EVVDGLEKAI 211 YKGP
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SAM or .SAM2 or .SAM3 or :3SAM;style chemicals stick;color identity;select .A:40 or .A:41 or .A:42 or .A:64 or .A:66 or .A:67 or .A:68 or .A:70 or .A:71 or .A:72 or .A:89 or .A:90 or .A:91 or .A:92 or .A:95 or .A:117 or .A:118 or .A:119 or .A:120 or .A:139 or .A:141 or .A:142 or .A:143 or .A:144 or .A:146 or .A:150; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
MET40
3.440
ASN41
3.721
VAL42
2.838
GLU64
3.935
GLY66
2.904
ALA67
3.582
TYR68
3.324
GLY70
4.543
TYR71
3.248
SER72
2.751
ILE89
3.692
GLU90
2.670
ILE91
3.221
|
|||||
PDB ID: 3BWM Crystal Structure of Human Catechol O-Methyltransferase with bound SAM and DNC | ||||||
Method | X-ray diffraction | Resolution | 1.98 Å | Mutation | No | [5] |
PDB Sequence |
GDTKEQRILN
11 HVLQHAEPGN21 AQSVLEAIDT31 YCEQKEWAMN41 VGDKKGKIVD51 AVIQEHQPSV 61 LLELGAYCGY71 SAVRMARLLS81 PGARLITIEI91 NPDCAAITQR101 MVDFAGVKDK 111 VTLVVGASQD121 IIPQLKKKYD131 VDTLDMVFLD141 HWKDRYLPDT151 LLLEECGLLR 161 KGTVLLADNV171 ICPGAPDFLA181 HVRGSSCFEC191 THYQSFLEYR201 EVVDGLEKAI 211 YKGP
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SAM or .SAM2 or .SAM3 or :3SAM;style chemicals stick;color identity;select .A:40 or .A:41 or .A:42 or .A:64 or .A:66 or .A:67 or .A:68 or .A:70 or .A:71 or .A:72 or .A:89 or .A:90 or .A:91 or .A:92 or .A:95 or .A:117 or .A:118 or .A:119 or .A:120 or .A:139 or .A:141 or .A:142 or .A:143 or .A:144 or .A:146; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
MET40
3.350
ASN41
3.665
VAL42
2.810
GLU64
4.045
GLY66
2.848
ALA67
3.634
TYR68
3.325
GLY70
4.575
TYR71
3.287
SER72
2.905
ILE89
3.840
GLU90
2.718
ILE91
3.252
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Equatorial Active Site Compaction and Electrostatic Reorganization in Catechol-O-methyltransferase. ACS Catal. 2019 May 3;9(5):4394-4401. | ||||
REF 2 | human catechol O-methyltransferase in complex with SAM and DNC at 1.50A | ||||
REF 3 | Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT). ACS Med Chem Lett. 2015 Jan 26;6(3):318-23. | ||||
REF 4 | Hit to Lead: Comprehensive Strategy of de novo Scaffold Generation by FBDD. Part 1: In silico Fragments Linking and Verification of Spatial Proximity using Inter Ligand NOE Approachs | ||||
REF 5 | Crystal structures of human 108V and 108M catechol O-methyltransferase. J Mol Biol. 2008 Jun 27;380(1):120-30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.